Thanks to the reduced risk of hypoglycemia with many agents including metformin, thiazolidinediones (TZDs), dipeptidyl peptidase 4 inhibitors (DPP4i), GLP-1 RA and SGLT2i, we advocate aiming for tighter glucose control. The gene discussed is GLP1R; the disease is Hypoglycemia.